Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: Control of viral replication and absence of persistent HIV-1- specific immune responses

Journal of Virology

Volumn 74, Issue 15, 2000, Pages 6984-6991

  Luzuriaga, Katherine ^a,b   McManus, Margaret ^a   Catalina, Michelle ^a   Mayack, Shane ^a   Sharkey, Mark ^a   Stevenson, Mario ^a   Sullivan, John L ^a   Gay, Hannah ^c   Vink, Peter ^d   Pahwa, Savita ^e   Bakshi, Saroj ^e   Borkowsky, William ^f   Cunningham, Colcen ^g   Pelton, Stephen ^h   Spector, Stephen ⁱ   Mofenson, Lynne ^j   Smith, Betsy ^k  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b Pediatrics/Molecular Medicine   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MARYLAND   (United States)

^e NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^f NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g SYRACUSE UNIVERSITY   (United States)

^h BOSTON MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^k NATIONAL INSTITUTES OF HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; LAMIVUDINE; NELFINAVIR; RITONAVIR; STAVUDINE; ZIDOVUDINE;

ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; PRIORITY JOURNAL; VIRUS REPLICATION;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CHILD, PRESCHOOL; DISEASE TRANSMISSION, VERTICAL; DRUG THERAPY, COMBINATION; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; LYMPHOCYTE ACTIVATION; REVERSE TRANSCRIPTASE INHIBITORS; RNA, VIRAL; T-LYMPHOCYTES, CYTOTOXIC; VIRAL LOAD; VIRUS REPLICATION;

EID: 17544371675     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.15.6984-6991.2000     Document Type: Article

References (36)

1. Abrams, E. J., J. Weedon, R. W. Steketee, G. Lambert, M. Bamji, T. Brown, M. L. Kalish, E. E. Schoenbaum, P. A. Thomas, D. M. Thea, and New York City Collaborative Study Group. 1998. Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. J. Infect. Dis. 178:101-108.
2. Altman, J., P. Moss, P. Goulder, D. Barouch, M. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Direct visualization and phenotypic analysis of virus-specific T lymphocytes in HIV-infected individuals. Science 274:94-96.
3. Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Investig. 97:77-89.
4. Brander, C., P. Goulder, K. Luzuriaga, O. Yang, K. Hartman, N. Jones, B. Walker, and S. Kalams. 1999. Persistent HIV-1 specific CTL clonal expansion despite high viral burden post in-utero HIV-1 infection. J. Immunol. 162:4796-4800.
5. Buseyne, F., M. Burgard, J. P. Teglas, E. Bui, C. Rouzioux, M. J. Mayaux, S. Blanche, and Y. Riviere. 1998. Early HIV-specific cytotoxic T lymphocytes and disease progression in children born to HIV-infected mothers. AIDS Res. Hum. Retroviruses 14:1435-1444.
6. Centers for Disease Control and Prevention. 1994. Revised classification system for HIV-1 infection in children less than 13 years of age. Morb. Mortal. Wkly. Rep. 43(RR-12):1-10.
7. Coffin, J. M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis and therapy. Science 267:483-489.
8. Daar, E. S. 1998. Virology and immunology of acute HIV type 1 infection. AIDS Res. Hum. Retroviruses 14:S-229-S-234.
9. Davis, M. M. 1998. Correction. Science 280:1821.
10. Dickover, R., M. Dillon, S. Gillette, A. Deveikis, M. Keller, S. Plaeger-Marshall, I. Chen, A. Diagne, E. R. Stiehm, and Y. Bryson. 1994. Rapid increases in load of human immunodeficiency virus correlate with early disease progression and loss of CD4 cells in vertically-infected infants. J. Infect. Dis. 170:1279-1284.
11. Gans, H., Y. Maldonado, L. L. Yasukawa, J. Beeler, S. Audet, M. M. Rinki, R. DeHovitz, and A. M. Arvin. 1999. IL-12, IFN-γ, and T cell proliferation to measles in immunized infants. J. Immunol. 162:5569-5575.
12. Gans, H. A., A. M. Arvin, J. Galinus, L. Logan, R. DeHovitz, and Y. Maldonado. 1998. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. JAMA 280:527-532.
13. Garboczi, D. N., D. T. Hung, and D. C. Wiley. 1992. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and completed with single antigenic peptides. Proc. Natl. Acad. Sci. USA 89:3429-3433.
14. Garcia, P. M., L. A. Kalish, J. Pitt, H. Minkoff, T. C. Quinn, S. K. Burchett, J. Kornegay, B. Jackson, J. Moye, C. Hanson, C. Zorrilla, and J. F. Lew. 1999. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. N. Engl. J. Med. 341:394-402.
15. Ho, D. D. 1997. Dynamics of HIV-1 replication in vivo. J. Clin. Investig. 99:2565-2567.
16. Lubaki, M. N., M. A. Egan, R. F. Siliciano, K. J. Weinhold, and R. C. Bollinger. 1994. A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes. AIDS Res. Hum. Retroviruses 10: 1427-1431.
17. Luzuriaga, K., Y. Bryson, P. Krogstad, J. Robinson, B. Stechenberg, M. Lamson, S. Cort, and J. L. Sullivan. 1997. Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection. N. Engl. J. Med. 336:1343-1349.
18. Luzuriaga, K., D. Holmes, A. Hereema, J. Wong, D. L. Panicali, and J. L. Sullivan. 1995. HIV-1-specific cytotoxic T lymphocyte responses in the first year of life. J. Immunol. 154:433-443.
19. Luzuriaga, K., R. A. Koup, C. A. Pikora, D. B. Brettler, and J. L. Sullivan. 1991. Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children. J. Pediatr. 119:230-236.
20. Luzuriaga, K., and J. L. Sullivan. 1996. DNA polymerase chain reaction for the diagnosis of vertical HIV infection. JAMA 275:1360-1361.
21. Luzuriaga, K., H. L. Wu, M. McManus, P. Britto, B. Smith, L. Mofenson, and J. L. Sullivan. 1999. Dynamics of HIV-1 replication in vertically-infected infants. J. Virol. 73:362-367.
22. Malhotra, U., M. M. Berrey, Y. Huang, J. Markee, D. J. Brown, S. Ap, L. Musey, T. Schacker, L. Corey, and M. J. McElrath. 2000. Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection. J. Infect. Dis. 181:121-131.
23. Markowitz, M., M. Vesanen, K. Tenner-Racz, Y. Cao, J. M. Binley, A. Talal, A. Hurley, X. Ji, M. R. Chaudhry, M. Yaman, S. Frankel, M. Heath-Chiozzi, J. M. Londard, J. P. Moore, P. Racz, D. F. Nixon, and D. D. Ho. 1999. The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses. J. Infect. Dis. 179:525-537.
24. McFarland, E. J., P. A. Harding, D. Luckey, B. Conway, R. K. Young, and D. R. Kuritzkes. 1994. High frequency of gag- and env-specific cytotoxic T lymphocyte precursors in children with vertically-acquired human immunodeficiency virus type 1 infection. J. Infect. Dis. 170:766-774.
25. Morris, L., J. M. Binley, B. A. Clas, S. Bonhoeffer, T. P. Astill, R. Kost, A. Hurley, Y. Cao, M. Markowitz, D. D. Ho, and J. P. Moore. 1998. HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy. J. Exp. Med. 188:233-245.
26. Moskophidis, D., F. Lechner, H. Pircher, and R. M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362:758-761.
27. Oxenius, A., D. A. Price, P. J. Easterbrook, C. A. O'Callaghan, A. D. Kelleher, J. A. Whelan, G. Sontag, A. K. Sewell, and R. E. Phillips. 2000. Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes. Proc. Natl. Acad. Sci. USA 97:3382-3387.
28. Pikora, C. A., J. L. Sullivan, D. Panicali, and K. Luzuriaga. 1997. Early HIV-1 envelope-specific cytotoxic T lymphocyte responses in vertically infected infants. J. Exp. Med. 185:1153-1161.
29. Pitcher, C. J., C. Quittner, D. M. Peterson, M. Connors, R. A. Koup, V. C. Maine, and L. J. Picker. 1999. HIV-1 specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nature Med. 5:518-525.
30. Rosenberg, E. S., J. M. Billingsley, A. M. Caliendo, S. L. Boswell, P. E. Sax, S. A. Kalams, and B. D. Walker. 1997. Vigorous HIV-1 specific CD4 T cell responses associated with control of viremia. Science 278:1447-1450.
31. Rosenberg, E. S., L. LaRosa, T. Flynn, G. Robbins, and B. D. Walker. 1999. Characterization of HIV-1 specific T-helper cells in acute and chronic infection. Immunol. Lett. 66:89-93.
32. Sharkey, M., I. Teo, T. Greenough, N. Sharkova, K. Luzuriaga, J. L. Sullivan, R. P. Bucy, L. G. Kostrikis, A. Haase, R. Davaro, S. H. Cheeseman, J. Daly, C. Bova, R. T. I. Ellison, B. Mady, K. K. Lai, G. Moyle, M. Nelson, B. Gazzard, S. Shaunak, and M. Stevenson. 2000. Persistence of episomal HIV-1 infection intermediates in patients on highly active antiretroviral therapy. Nat. Med. 6:76-81.
33. Smith, S., R. F. Jacobs, and C. B. Wilson. 1997. Immunobiology of childhood tuberculosis: a window on the ontogeny of cellular immunity. J. Pediatr. 131:16-26.
34. Van Rompay, K. K., P. J. Dailey, R. P. Tarara, D. R. Canfield, N. L. Aguirre, J. M. Cherrington, P. D. Lamy, N. Bischofberger, N. C. Pedersen, and M. L. Marthas. 1999. Early short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine treatment favorably alters the subsequent disease course in simian immunodeficiency virus-infected newborn rhesus macaques. J. Virol. 73: 2947-2955.
35. Van Rompay, K. K., M. G. Otsyula, M. L. Marthas, C. J. Miller, M. B. McChesney, and N. C. Pedersen. 1995. Immediate zidovudine treatment protects simian immunodeficiency virus-infected newborn macaques against rapid onset of AIDS. Antimicrob. Agents Chemother. 39:125-131.
36. Wilson, C. B., J. Westall, L. Johnston, D. B. Lewis, S. K. Dower, and A. R. Alpert. 1986. Decreased production of interferon gamma by human neonatal cells: intrinsic and regulatory deficiencies. J. Clin. Investig. 77:860-867.